IRIS
BALBI, MATILDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.311
Totale 1.311
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.311
Totale 1.311
Salva come PNG Salva come JPEG
Città #
Genova 532
Genoa 342
Vado Ligure 229
Rapallo 196
Bordighera 12
Totale 1.311
Salva come PNG Salva come JPEG
Nome #
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of Glutamate and GABA in the mouse cortex and hippocampus 161
Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. 157
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 105
Group I metabotropic glutamatergic receptors regulating glutamate release and microglia phenotype in a murine model of amyotrophic lateral sclerosis 97
GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 74
Glucagon Like Peptide-1 increases glutamate release in the mouse cerebral cortex and hippocampus by activacting presynaptic GLP-1R 59
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 59
cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 56
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 52
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 47
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 45
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 45
PRESYNAPTIC GLP-1 RECEPTORS ENHANCE GLUTAMATE AND GABA RELEASE FROM PURIFIED MOUSE CORTICAL AND HIPPOCAMPAL SYNAPTOSOMES 41
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 41
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression 37
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 29
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 29
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 28
The partial deletion of mGluR5 affects the pro- and anti-inflammatory and bioenergetic characteristics of microglia during ALS progression in SOD1(G93A) mice 28
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 27
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 24
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 21
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis 20
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice 15
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 15
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 14
MSC-derived extracellular vesicles for the treatment of ALS 12
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 9
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 9
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 8
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 8
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 8
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 7
Synapto-gliosomal characterization in a zebrafish model of Alexander disease 4
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 4
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 2
null 1
null 1
Totale 1.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.950
article - articoli 2.638
book - libri 0
conference - conferenze 3.055
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 0 0 0 0 14 22 33 23 16 43 27 2
2020/2021103 3 10 4 3 2 15 11 7 6 26 11 5
2021/2022182 1 8 13 11 7 10 23 37 17 16 17 22
2022/2023245 24 20 7 19 21 28 2 22 50 6 44 2
2023/2024301 6 23 23 32 29 48 19 18 4 20 28 51
2024/2025265 56 47 24 80 58 0 0 0 0 0 0 0
Totale 1.399